Data / Drug companies / Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.: 27 products in the FDA NDC directory, labeler code 58623
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Zhejiang Hisun Pharmaceutical Co., Ltd. (labeler code 58623) lists 27 products in the FDA National Drug Code Directory. By type: 27 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on April 24, 2025.
The request: Watch Zhejiang Hisun Pharmaceutical Co., Ltd. (FDA labeler code 58623): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 58623
- Products in commercial distribution
- 27
- Packages
- 61
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- May 11, 1994
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 27 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 27 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 27 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Emodepside | 58623-0139 | Powder | Bulk ingredients | April 24, 2025 |
| Doxorubicin hydrochloride | 58623-0119 | Powder | Bulk ingredients | September 5, 2019 |
| Anastrozole | 58623-0041 | Powder | Bulk ingredients | September 5, 2019 |
| Zeranol | 58623-0135 | Powder | Bulk ingredients | September 4, 2019 |
| Minocycline hydrochloride | 58623-0133 | Powder | Bulk ingredients | September 4, 2019 |
| Bleomycin sulfate | 58623-0033 | Powder | Bulk ingredients | August 12, 2019 |
| Mitomycin | 58623-0045 | Powder | Bulk ingredients | August 5, 2019 |
| Adenosine | 58623-0061 | Powder | Bulk ingredients | July 25, 2019 |
| Ticagrelor | 58623-0131 | Powder | Bulk ingredients | October 12, 2018 |
| Donepezil hydrochloride | 58623-0116 | Powder | Bulk ingredients | July 27, 2018 |
| Micafungin sodium | 58623-0113 | Powder | Bulk ingredients | April 20, 2018 |
| Tigecycline | 58623-0048 | Powder | Bulk ingredients | January 18, 2018 |
| Eprinomectin | 58623-0086 | Powder | Bulk ingredients | January 16, 2018 |
| Ivermectin | 58623-0047 | Powder | Bulk ingredients | October 24, 2014 |
| Methotrexate | 58623-0040 | Powder | Bulk ingredients | March 29, 2012 |
| Milbemycin oxime | 58623-0089 | Powder | Bulk ingredients | January 4, 2011 |
| Mesna | 58623-0039 | Powder | Bulk ingredients | April 13, 2010 |
| Dactinomycin | 58623-0098 | Powder | Bulk ingredients | March 16, 2010 |
| Cyclophosphamide | 58623-0024 | Powder | Bulk ingredients | March 12, 2009 |
| Acarbose | 58623-0022 | Powder | Bulk ingredients | May 7, 2008 |
| Fludarabine phosphate | 58623-0043 | Powder | Bulk ingredients | October 15, 2007 |
| Cladribine | 58623-0037 | Powder | Bulk ingredients | April 22, 2004 |
| Mevastatin | 58623-0077 | Powder | Bulk ingredients | March 29, 2004 |
| Cytarabine | 58623-0026 | Powder | Bulk ingredients | January 15, 2004 |
| Lovastatin | 58623-0021 | Powder | Bulk ingredients | September 17, 1996 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.